UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Use financial data to refine your budget with practical steps that help identify waste and improve allocation. This intro explains a data-driven approach to smarter budgeting.
27,071 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
March 2026 yielded an all-time high for new business registrations, with 624,915 formations, followed by 560,194 in A...
New data highlights a tougher entry to the workforce for Gen Z graduates compared with Millennials, with a large shar...
Redfin highlights several Midwest areas as hot markets. This guide breaks down what that means for investors, loan op...
An ETF that seemed to outpace the market has many investors wondering if it belongs in their portfolio. This guide ex...
A quiet market signal could hint at trouble ahead. This article explains what the under-the-radar index signaling mea...
A china tech fund opens a biotech position, signaling a broader shift toward life sciences within tech-driven portfol...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Palantir has won a landmark Army data overhaul deal worth $10 billion, signaling a decade-long shift in defense IT an...
The idea of lifelong renters isn’t just a buzzword—it's reshaping how landlords approach financing, property manageme...
Looking for growth you can ride for years? This guide breaks down three powerhouse names—NVIDIA, Microsoft, and Alpha...
Regulatory headlines have a way of rattling investors, especially in high-growth tech sectors. This article dives int...